ABIGAIL OMOJOLA

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Proposals to reform FDA authority and personal care products regulatory system. Specific bills include the Toxic Free Beauty Act (H.R. 5537), Cosmetic Fragrance and Flavor Ingredient Right to Know Act (H.R. 5538), Cosmetic Safety for Communities of Color and Professional Salon Workers Act (H.R. 5540), Cosmetic Supply Chain Transparency Act (H.R. 5539), No PFAS in Cosmetics Act (H.R. 3990/S.2047), Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act (S.2100); Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act (H.R. 5872). Funding for Centers for Disease Control Biomonitoring program and National Health Tracking Network in FY 2022 and FY 2023 Labor-HHS-Education bill. Proposals to reform the FDA's GRAS standard and food-packaging related legislation, including the Toxic Free Food Act (H.R. 3699), Preventing Harmful Exposure to Phthalates Act (H.R. 4963/S.2669), Keep Food Containers Safe from PFAS Act (H.R. 6026/S.3169), and the Food Chemical Reassessment Act of 2021 (H.R. 4694).

Proposals to reform FDA authority and personal care products regulatory system. Specific bills include the Toxic Free Beauty Act (H.R. 5537), Cosmetic Fragrance and Flavor Ingredient Right to Know Act (H.R. 5538), Cosmetic Safety for Communities of Color and Professional Salon Workers Act (H.R. 5540), Cosmetic Supply Chain Transparency Act (H.R. 5539), No PFAS in Cosmetics Act (H.R. 3990/S.2047), Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act (S.2100); Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act (H.R. 5872). Funding for Centers for Disease Control Biomonitoring program and National Health Tracking Network in FY 2022 and FY 2023 Labor-HHS-Education bill. Proposals to reform the FDA's GRAS standard and food-packaging related legislation, including the Toxic Free Food Act (H.R. 3699), Preventing Harmful Exposure to Phthalates Act (H.R. 4963/S.2669), Keep Food Containers Safe from PFAS Act (H.R. 6026/S.3169), and the Food Chemical Reassessment Act of 2021 (H.R. 4694).

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the No PFAS in Cosmetics Act (H.R. 3990/S.2047), Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act (S.2100); Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act. Funding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill. Proposals to reform the FDA's GRAS standard and food-packaging related legislation, including the Toxic Free Food Act (H.R. 3699), the Preventing Harmful Exposure to Phthalates Act (H.R. 4963/S.2669), and the Food Chemical Reassessment Act of 2021 (H.R. 4694).

Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the No PFAS in Cosmetics Act (H.R. 3990/S.2047), Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act (S.2100); Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act. Funding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill. Proposals to reform the FDA's GRAS standard and food-packaging related legislation, including the Toxic Free Food Act (H.R. 3699), the Preventing Harmful Exposure to Phthalates Act (H.R. 4963/S.2669), and the Food Chemical Reassessment Act of 2021 (H.R. 4694).

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380);the Fresh Start Act (H.R. 5651 / S.3049); and reforms to the Fair Credit Reporting Act.

Advance the implementation of the Executive Order to Promote Voting Access. Advocate for passage of the "For the People Act of 2021" (H.R. 1 and S.1), specifically the bills' public financing, small donor provisions.

Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the No PFAS in Cosmetics Act (H.R. 3990/S.2047), Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act (S.2100); Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act. Funding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill. Proposals to reform the FDA's GRAS standard and food-packaging related legislation, including the Toxic Free Food Act (H.R. 3699), the Preventing Harmful Exposure to Phthalates Act (H.R. 4963/S.2669), and the Food Chemical Reassessment Act of 2021 (H.R. 4694).

Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the No PFAS in Cosmetics Act (H.R. 3990/S.2047), Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act (S.2100); Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act. Funding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill. Proposals to reform the FDA's GRAS standard and food-packaging related legislation, including the Toxic Free Food Act (H.R. 3699), the Preventing Harmful Exposure to Phthalates Act (H.R. 4963/S.2669), and the Food Chemical Reassessment Act of 2021 (H.R. 4694).

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380); the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380); the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380); the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380); the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380); the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380); the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including American Rescue Plan Act (Pub L. No. 117-2) implementation; the Build Back Better Act (H.R.5376) and budget reconciliation process; the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills; the Clean Slate Act (H.R. 2864 / S. 1380); the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611); and reforms to the Fair Credit Reporting Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the American Rescue Plan Act of 2021 (H.R. 1319) and implementation, the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills, the Clean Slate Act (H.R. 2864 / S. 1380), and the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611).

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the American Rescue Plan Act of 2021 (H.R. 1319) and implementation, the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills, the Clean Slate Act (H.R. 2864 / S. 1380), and the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611).

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the American Rescue Plan Act of 2021 (H.R. 1319) and implementation, the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills, the Clean Slate Act (H.R. 2864 / S. 1380), and the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611).

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the American Rescue Plan Act of 2021 (H.R. 1319) and implementation, the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills, the Clean Slate Act (H.R. 2864 / S. 1380), and the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611).

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the American Rescue Plan Act of 2021 (H.R. 1319) and implementation, the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills, the Clean Slate Act (H.R. 2864 / S. 1380), and the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611).

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the American Rescue Plan Act of 2021 (H.R. 1319) and implementation, the Fiscal Year 2022 Commerce, Justice, Sciences and Related Agencies and Labor, Health and Human Services, and Education appropriations bills, the Clean Slate Act (H.R. 2864 / S. 1380), and the VOCA Fix to Sustain the Crime Victims Fund Act (H.R. 1652 / S. 611).

Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act. Funding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.

Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act. Funding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.

Advance the implementation of the Executive Order to Promote Voting Access. Advocate for passage of the "For the People Act of 2021" (H.R. 1 and S.1), specifically the bills' public financing, small donor provisions.

Advance the implementation of the Executive Order to Promote Voting Access. Advocate for passage of the "For the People Act of 2021" (H.R. 1 and S.1), specifically the bills' public financing, small donor provisions. Advocate for the passage of the "Washington, D.C. Admission Act" (H.R. 51 and S. 51).

Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act. Funding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.

Proposals to reform FDA authority and personal care products regulatory system. Legislation that would strengthen supply chain transparency and safety of raw ingredients in cosmetics; ban toxic ingredients linked to harmful impacts on health; full fragrance and flavor ingredient disclosure; and health protections, including a ban on chemicals of concern in products marketed to women of color. Specific bills include the Safe Cosmetics and Personal Care Products Act, Personal Care Products Safety Act; Cosmetic Safety Enhancement Act; and the Natural Cosmetics Act. Funding for Centers for Disease and Control Biomonitoring program and National Health Tracking Network in FY 22 Labor-HHS-Education bill.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the American Rescue Plan Act of 2021, H.R. 1319 and the FY 2022 appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the American Rescue Plan Act of 2021, H.R. 1319 and the FY 2022 appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the American Rescue Plan Act of 2021, H.R. 1319 and the FY 2022 appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the American Rescue Plan Act of 2021, H.R. 1319 and the FY 2022 appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the American Rescue Plan Act of 2021, H.R. 1319 and the FY 2022 appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the American Rescue Plan Act of 2021, H.R. 1319 and the FY 2022 appropriations bills.

Proposals to reform FDA authority and personal care products regulatory system. Specifically, H.R. 4296 - Safe Cosmetics and Personal Care Products Act; S.726 - Personal Care Products Safety Act; H.R. 5279 - Cosmetic Safety Enhancement Act; and H.R. 5017 - Natural Cosmetics Act.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

HOUSE AND SENATE APPROPRIATIONS Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reforming and strengthening the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296 - Safe Cosmetics and Personal Care Products Act; S.726 - Personal Care Products Safety Act; H.R. 5279 - Cosmetic Safety Enhancement Act; H.R. 5017 - Natural Cosmetics Act; and additional proposals that would impact the regulation of cosmetics and personal care products. Breast Cancer Prevention Partners visits Congressional offices to oppose H.R. 6044 - Accurate Labels Act, and other legislative proposals that seek to undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. These include H.R. 5986 - Environmental Justice for All Act and S.2236 - Environmental Justice Act of 2019. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural". REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reforming and strengthening the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296 - Safe Cosmetics and Personal Care Products Act; S.726 - Personal Care Products Safety Act; H.R. 5279 - Cosmetic Safety Enhancement Act; H.R. 5017 - Natural Cosmetics Act; and additional proposals that would impact the regulation of cosmetics and personal care products. Breast Cancer Prevention Partners visits Congressional offices to oppose H.R. 6044 - Accurate Labels Act, and other legislative proposals that seek to undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. These include H.R. 5986 - Environmental Justice for All Act and S.2236 - Environmental Justice Act of 2019. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural". REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reforming and strengthening the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296 - Safe Cosmetics and Personal Care Products Act; S.726 - Personal Care Products Safety Act; H.R. 5279 - Cosmetic Safety Enhancement Act; H.R. 5017 - Natural Cosmetics Act; and additional proposals that would impact the regulation of cosmetics and personal care products. Breast Cancer Prevention Partners visits Congressional offices to oppose H.R. 6044 - Accurate Labels Act, and other legislative proposals that seek to undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. These include H.R. 5986 - Environmental Justice for All Act and S.2236 - Environmental Justice Act of 2019. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural". REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

Issues relating to public safety, community health, and criminal justice reform legislation and policies, including the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, H.R. 6800, the Paycheck Protection Program Second Chance Act, S.3865, and the FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations bills.

ASJ advocates for policies/programs that will increase community safety and improve public health, with a focus on meeting the needs of crime survivors, people returning home from prison, and community-based organizations that support them, including advocating for availability of such resources within any COVID-19 relief bills; Congressional appropriations bills and resolutions for the upcoming year (FY 2021); and other relevant legislative and regulatory efforts that emerge.

ASJ advocates for policies/programs that will increase community safety and improve public health, with a focus on meeting the needs of crime survivors, people returning home from prison, and community-based organizations that support them, including advocating for availability of such resources within any COVID-19 relief bills; Congressional appropriations bills and resolutions for the upcoming year (FY 2021); and other relevant legislative and regulatory efforts that emerge.

ASJ advocates for policies/programs that will increase community safety and improve public health, with a focus on meeting the needs of crime survivors, people returning home from prison, and community-based organizations that support them, including advocating for availability of such resources within any COVID-19 relief bills; Congressional appropriations bills and resolutions for the upcoming year (FY 2021); and other relevant legislative and regulatory efforts that emerge.

ASJ advocates for policies/programs that will increase community safety and improve public health, with a focus on meeting the needs of crime survivors, people returning home from prison, and community-based organizations that support them, including advocating for availability of such resources within any COVID-19 relief bills; Congressional appropriations bills and resolutions for the upcoming year (FY 2021); and other relevant legislative and regulatory efforts that emerge.

ASJ advocates for policies/programs that will increase community safety and improve public health, with a focus on meeting the needs of crime survivors, people returning home from prison, and community-based organizations that support them, including advocating for availability of such resources within any COVID-19 relief bills; Congressional appropriations bills and resolutions for the upcoming year (FY 2021); and other relevant legislative and regulatory efforts that emerge.

ASJ advocates for policies/programs that will increase community safety and improve public health, with a focus on meeting the needs of crime survivors, people returning home from prison, and community-based organizations that support them, including advocating for availability of such resources within any COVID-19 relief bills; Congressional appropriations bills and resolutions for the upcoming year (FY 2021); and other relevant legislative and regulatory efforts that emerge.

ASJ advocates for policies/programs that will increase community safety and improve public health, with a focus on meeting the needs of crime survivors, people returning home from prison, and community-based organizations that support them, including advocating for availability of such resources within any COVID-19 relief bills; Congressional appropriations bills and resolutions for the upcoming year (FY 2021); and other relevant legislative and regulatory efforts that emerge.

HOUSE AND SENATE APPROPRIATIONS Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reforming and strengthening the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296 - Safe Cosmetics and Personal Care Products Act; S.726 - Personal Care Products Safety Act; H.R. 5279 - Cosmetic Safety Enhancement Act; H.R. 5017 - Natural Cosmetics Act; and additional proposals that would impact the regulation of cosmetics and personal care products. Breast Cancer Prevention Partners visits Congressional offices to oppose H.R. 6044 - Accurate Labels Act, and other legislative proposals that seek to undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. These include H.R. 5986 - Environmental Justice for All Act and S.2236 - Environmental Justice Act of 2019. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural". REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reforming and strengthening the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296 - Safe Cosmetics and Personal Care Products Act; S.726 - Personal Care Products Safety Act; H.R. 5279 - Cosmetic Safety Enhancement Act; H.R. 5017 - Natural Cosmetics Act; and additional proposals that would impact the regulation of cosmetics and personal care products. Breast Cancer Prevention Partners visits Congressional offices to oppose H.R. 6044 - Accurate Labels Act, and other legislative proposals that seek to undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. These include H.R. 5986 - Environmental Justice for All Act and S.2236 - Environmental Justice Act of 2019. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural". REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reforming and strengthening the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296 - Safe Cosmetics and Personal Care Products Act; S.726 - Personal Care Products Safety Act; H.R. 5279 - Cosmetic Safety Enhancement Act; H.R. 5017 - Natural Cosmetics Act; and additional proposals that would impact the regulation of cosmetics and personal care products. Breast Cancer Prevention Partners visits Congressional offices to oppose H.R. 6044 - Accurate Labels Act, and other legislative proposals that seek to undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. These include H.R. 5986 - Environmental Justice for All Act and S.2236 - Environmental Justice Act of 2019. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural". REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296, the Safe Cosmetics and Personal Care Products Act of 2019, S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural". REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296, the Safe Cosmetics and Personal Care Products Act of 2019, S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural". REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296, the Safe Cosmetics and Personal Care Products Act of 2019, S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural". REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296, the Safe Cosmetics and Personal Care Products Act of 2019, S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural". REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296, the Safe Cosmetics and Personal Care Products Act of 2019, S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural". REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes H.R. 4296, the Safe Cosmetics and Personal Care Products Act of 2019, S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. Breast Cancer Prevention Partners supports legislation that increases transparency and addresses personal care products labeled or packaged as "natural". REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. Breast Cancer Prevention Partners supports efforts to increase federal funding for research and to regulate per- and polyfluoroalkyl substances (PFAS). Breast Cancer Prevention Partners supports legislation that would strengthen public health restrictions and set new standards on ethylene oxide emissions. REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) CURRENT LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system and is working to ensure strong, health-protective measures are included in any proposed legislation. This includes S.726, the Personal Care Products Safety Act, and any other legislation that would impact the regulation of personal care products. FUTURE LEGISLATIVE PROPOSALS: Breast Cancer Prevention Partners visits Congressional offices to oppose legislative proposals that undermine transparency for consumers and undermine states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that establishes environmental justice as a consideration in the regulation of pesticides and personal care products. Breast Cancer Prevention Partners supports efforts to reintroduce legislation that would ban food containers composed, in whole or in part, of bisphenol A (BPA). Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. REGULATION AND LEGISLATIVE INTENT: P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act - The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the reforms enacted in the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products including H.R. 6903, the Safe Cosmetics and Personal Care Products Act of 2018. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products including H.R. 6903, the Safe Cosmetics and Personal Care Products Act of 2018. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products including H.R. 6903, the Safe Cosmetics and Personal Care Products Act of 2018. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products including H.R. 6903, the Safe Cosmetics and Personal Care Products Act of 2018. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products including H.R. 6903, the Safe Cosmetics and Personal Care Products Act of 2018. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products including H.R. 6903, the Safe Cosmetics and Personal Care Products Act of 2018. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. The Breast Cancer Prevention Partners supports reform and strengthening of the personal care products regulatory system, and is working to ensure strong, health protective measures are included in legislation such as S.1113, the Personal Care Products Safety Act, and any other legislation that would impact the safety of personal care products. Breast Cancer Prevention Partners opposes the Accurate Labels Act (S.3019, H.R.6022) because it undermines transparency for consumers and undermines states' ability to protect the public health of their citizens by preempting science-based ingredient labeling for consumer goods. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).